The Satisfactory Analgesia and Minimal Emesis of Elderly Patients After Thoracoscopic Lung Surgery: Oliceridine versus Sufentanil in a Randomized Controlled Trial
Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-10
DOI: 10.2147/dddt.s593306 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Yongliang Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210000, People's Rep…. Hauptthemen laut MEDLINE: Sufentanil, Thoracoscopy, Thiophenes, Postoperative Pain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
To compare oliceridine with sufentanil for the proportion of elderly patients achieving satisfactory analgesia with minimal emesis (SAME) after thoracoscopic lung surgery.
Methods
This prospective, double-blind, randomized controlled trial enrolled elderly patients aged 65-80 years scheduled for thoracoscopic lung surgery to receive patient-controlled intravenous analgesia with either oliceridine or sufentanil. The primary outcome was the proportion of patients achieving SAME within the first 3 postoperative days, defined as a daily average coughing numerical rating scale (NRS) pain score < 4 and daily highest postoperative nausea and vomiting (PONV) score < 2. The secondary outcomes included NRS pain scores, rescue analgesia, 15-item Quality of Recovery (QoR-15) scores, safety outcomes, time to ambulation, and postoperative length of stay.
Results
Among the 247 patients analyzed, oliceridine was associated with a higher proportion of patients achieving the SAME endpoint within the first 3 postoperative days compared with sufentanil (46.3% vs 32.3%; P = 0.023). Furthermore, the patients with oliceridine demonstrated lower NRS scores on POD1 (3.6 ± 1.9 vs 4.4 ± 2.1; P = 0.018) and POD2 (3.2 ± 1.2 vs 3.7 ± 1.3; P = 0.039), less requirement for rescue analgesia (P = 0.021), and higher QoR-15 scores on POD1 (P < 0.001) and POD2 (P = 0.010). Oliceridine also reduced the time to first ambulation (19 h [16, 22] vs 22 h [18, 25]; P < 0.001). No significant difference was observed in postoperative length of stay or safety outcomes.
Conclusion
Oliceridine, compared with sufentanil for postoperative analgesia, increased the proportion of achieving SAME within the first 3 PODs, provided better analgesia, and improved postoperative recovery quality with comparable safety outcomes for elderly patients undergoing thoracoscopic lung surgery. Trial Registration: www.chictr.org.cn, ChiCTR2500102213.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210000, People's Republic of China.
ORCID-Profile: Jianjun Yang, Heliang Sun
Zitieren
APA
Cai, Y., Jiang, Y., Zhang, Q., Yang, J., Wang, Z., & Sun, H. (2026). The Satisfactory Analgesia and Minimal Emesis of Elderly Patients After Thoracoscopic Lung Surgery: Oliceridine versus Sufentanil in a Randomized Controlled Trial. Drug Design, Development and Therapy, Volume 20, 1-10. https://doi.org/10.2147/dddt.s593306
Vancouver
Cai Y, Jiang Y, Zhang Q, Yang J, Wang Z, Sun H. The Satisfactory Analgesia and Minimal Emesis of Elderly Patients After Thoracoscopic Lung Surgery: Oliceridine versus Sufentanil in a Randomized Controlled Trial. Drug Design, Development and Therapy. 2026;Volume 20:1-10. doi:10.2147/dddt.s593306
BibTeX
@article{Cai2026,
author = {Cai, Yongliang and Jiang, Yihao and Zhang, Qingwei and Yang, Jianjun and Wang, Zhongyun and Sun, Heliang},
title = {The Satisfactory Analgesia and Minimal Emesis of Elderly Patients After Thoracoscopic Lung Surgery: Oliceridine versus Sufentanil in a Randomized Controlled Trial},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--10},
doi = {10.2147/dddt.s593306}
}
EUVIMED